Poly Lactic-Co-Glycolic Acid- (PLGA-) Loaded Nanoformulation of Cisplatin as a Therapeutic Approach for Breast Cancers

Figure 6

Measurement of ROS generation after a time-dependent treatment (12 and 24 h) of 23 μg/mL PLGA-cisplatin (DAPI-nuclear stainer).